Stock Events

Stock Events

Illumin 

$1.63
133
-$0.03-1.81% Friday 21:59

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

8NovExpected
Q1 2023
Q2 2023
Q3 2023
-0.07
-0.06
-0.04
-0.03
Expected EPS
-0.07
Actual EPS
N/A

Financials

-0.91%Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
91.54MRevenue
-829,215.42Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ILLM. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap19.48B
Illumina, Inc. is a direct competitor in the genomic sequencing space, offering similar sequencing and array technologies.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific provides comprehensive solutions including instruments, reagents, and software for research, analysis, discovery, and diagnostics that compete with Illumin's offerings.
Pacific Biosciences of California
PACB
Mkt Cap404.68M
Pacific Biosciences of California offers long-read sequencing technologies that compete with Illumin's short-read sequencing platforms.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. offers a range of products for the life science research and clinical diagnostics markets, competing in the genomic and molecular diagnostics space.
Qiagen NV
QGEN
Mkt Cap10.16B
Qiagen N.V. provides sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research, competing in the nucleic acid solutions market.
Agilent Technologies
A
Mkt Cap32.66B
Agilent Technologies, Inc. provides instruments, software, services, and consumables for the entire laboratory workflow, competing with Illumin in the genomics and molecular diagnostics sectors.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG offers diagnostic and research tools that compete with Illumin's genomic solutions, particularly in the sequencing and array-based technologies.
Quest Diagnostics
DGX
Mkt Cap22.03B
Quest Diagnostics incorporates genomic sequencing into its diagnostic testing services, competing indirectly with Illumin by offering similar diagnostic solutions.
Intellia Therapeutics
NTLA
Mkt Cap1.55B
Intellia Therapeutics, Inc. is involved in CRISPR/Cas9 technology, a gene editing technology that requires sequencing, indirectly competing with Illumin's sequencing technologies.
Editas Medicine
EDIT
Mkt Cap261.32M
Editas Medicine, Inc. also works in the gene editing space with CRISPR technology, relying on genomic sequencing technologies similar to those offered by Illumin for its research and development.

About

illumin Holdings Inc., a technology company, provides digital media solutions in the United States, Canada, Europe, Latin America, and internationally. The company offers a programmatic marketing platform that enables advertisers to connect with their audiences across online display, video, connected TV, social, and mobile campaigns. Its platform allows advertisers to manage their purchasing of online display advertising in real-time using programmatic ad buying. In addition, the company offers illumin platform, an advertising automation technology that provides planning, media buying, and omnichannel intelligence, as well as allows advertisers to map their consumer journey playbooks across screens and execute in real-time using programmatic technology. It serves Fortune 500 enterprises and small to mid-sized businesses. The company was formerly known as AcuityAds Holdings Inc. and changed its name to illumin Holdings Inc. in June 2023. illumin Holdings Inc. was founded in 2009 and is headquartered in Toronto, Canada.
Show more...
CEO
ISIN
CA45232V1067
WKN
000A2AN2K

Listings

TO
CA
ILLM.TO
OTC Link
US
ILLMF
F
DE
K3S0.F

0 Comments

Share your thoughts

FAQ

What is Illumin stock price today?▼
The current price of ILLM is $1.63 USD — it has decreased by -1.81% in the past 24 hours. Watch Illumin stock price performance more closely on the chart.
What is Illumin stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Illumin stocks are traded under the ticker ILLM.
What is Illumin revenue for the last year?▼
Illumin revenue for the last year amounts to 91.54M USD.
What is Illumin net income for the last year?▼
ILLM net income for the last year is -829,215.42 USD.
When did Illumin complete a stock split?▼
Illumin has not had any recent stock splits.